Adamantinomatous Craniopharyngioma
📧 Sign up to get email alerts when something new happens for Adamantinomatous Craniopharyngioma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: ACTEMRA® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma [Phase 2]
Phase 2 clinical trial evaluating tocilizumab (Actemra) for pediatric adamantinomatous craniopharyngioma is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: FOG-001 in Locally Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]
FOG-001 is being studied in a Phase 1/2 trial across multiple locally advanced or metastatic solid tumors and is currently recruiting; indic…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: MEKTOVI® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma [Phase 2]
MEKTOVI (binimetinib) is being studied in a Phase 2 pediatric trial for adamantinomatous craniopharyngioma, with recruitment currently ongoi…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Tocilizumab in Children With ACP [EARLY_Phase 1]
EARLY_PHASE1 trial update describing Tocilizumab in pediatric Adamantinomatous craniopharyngioma; the study is active but not currently recr…